Standout Papers
Citation Impact
Citing Papers
Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
2008
Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer
2007
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
2008
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
An Integrated Approach for Analysis of the DNA Damage Response in Mammalian Cells
2015 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
1996
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients
2008
Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection
1990
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Pneumothorax in AIDS
1991
An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency Virus
1992 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Mycobacteria other than tuberculosis. Pulmonary involvement in patients with acquired immunodeficiency syndrome
1988
Successful re-treatment with taxol after major hypersensitivity reactions.
1993
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
2005
Bleomycins: towards better therapeutics
2005
Lung Cancer
2008 Standout
Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer
2008
Paclitaxel (Taxol)
1995 Standout
Protective Reconstitution of the SCID Mouse against Reactivation of Toxoplasmic Encephalitis
1994
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Spontaneous Pneumothorax
2000 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Primary Pulmonary Hypertension
1997 Standout
Newer Methods for Diagnosis of Cytomegalovirus Infection
1990
Primary Pulmonary Hypertension in HIV Infection
1991
Oral Therapy forPneumocystis cariniiPneumonia in the Acquired Immunodeficiency Syndrome
1990
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
2010
Glucocorticoids and invasive fungal infections
2003
Pneumothorax with Pneumocystis carinii Pneumonia in AIDS
1991
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Cetuximab in advanced non-small cell lung cancer
2006
Trying to compose the puzzle with all the pieces: Epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer
2005
Medical management of patients with brain tumors
2006
Malignant Gliomas in Adults
2008 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial
2006
Trends in Hospital Volume and Operative Mortality for High-Risk Surgery
2011 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment
1990
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene?
1997
Absence of Bacteremia with Mycobacterium avium-intracellulare in Ugandan Patients with AIDS
1990
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer
2005
Kaposi's Sarcoma
2000 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
2010
Infection in Organ-Transplant Recipients
1998 Standout
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
1989 Standout
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer
2007
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
2006
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
2007
Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B
2007
CYTOMEGALOVIRUS
1994
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Managing Immune Checkpoint-Blocking Antibody Side Effects
2015
Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study
2005
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Immunology: Approaches to AIDS therapy
1986 StandoutNatureNobel
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
2003 Standout
Tuberculosis and the Acquired Immunodeficiency Syndrome at a New York City Hospital: 1978-1985
1987
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Use of Bronchoalveolar Lavage to Diagnose Acute Diffuse Pneumonia in the Immunocompromised Host
1986 StandoutNobel
Managing Cough as a Defense Mechanism and as a Symptom
1998
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1991
A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.
1985
Bacterial Pneumonia in Patients with the Acquired Immunodeficiency Syndrome
1986
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps—From the American Society of Clinical Oncology
2009
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
2009
Toxicities of Immunotherapy for the Practitioner
2015
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
1991
Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome
1986
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
2016
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
The Acquired Immunodeficiency Syndrome: An Update
1985
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis
2000
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
2007
Predictors of the Response to Gefitinib in Refractory Non–Small Cell Lung Cancer
2005
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995
Works of Diane E. Stover being referenced
Pulmonary Complications of the Acquired Immunodeficiency Syndrome: An Update
2015
The Use of a Simple Exercise Test for the Diagnosis of Pneumocystis carinii Pneumonia in Patients with AIDS
1989
Methotrexate Pneumonitis: Bronchoalveolar Lavage Findings Suggest an Immunologic Disorder
1989
Lung Cancer Prevention*
2003
Bronchoalveolar lavage cell populations in bleomycin lung toxicity.
1987
Lobectomy improves ventilatory function in selected patients with severe COPD
1998
Pneumocystis carinii Pneumonia in Patients With Primary Brain Tumors
1991
Organizing Pneumonia as a Side Effect of Ipilimumab Treatment of Melanoma
2013
Pulmonary Complications of the Acquired Immunodeficiency Syndrome
1984
Severe Bleomycin-Induced Pneumonitis
1984
Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome
1986
Bronchoalveolar Lavage in the Diagnosis of Diffuse Pulmonary Infiltrates in the Immunosuppressed Host
1984
NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop.
1987
Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome
1985
Phase II trial of neocarzinostatin in patients with bladder and prostatic cancer. Toxicity of a five-day IV bolus schedule
1980
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout